ClinicalTrials.Veeva

Menu

Stroke Registration of Young Adults in China (REACH)

Y

Yi Yang

Status

Enrolling

Conditions

Ischemic Stroke

Treatments

Other: Treatment following current guidelines

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a multi-center, prospective,continuous registry study. The investigators will include 3000 young adult (18-45 years old) patients with confirmed first-ever acute ischemic stroke in China. The main purpose of this study is to build the study cohort of young ischemic stroke patients in China, and to compare the prognosis and stroke recurrence of young patients with different ischemic stroke subtypes. Secondary objectives are trying to find biomarkers of stroke recurrence.

Full description

Approximately 10%-14% of all ischemic strokes occur in young adults ages 18 to 45 years old. Stroke etiology in this population differs by geographic region and has greater heterogeneity than in older individuals. Ascertain the definite etiologic classification in this young patients might be the key point to prevent the stroke recurrence and reduce the stroke burden. Advances in stroke diagnostic tests, particularly neuroimaging, refinement in classification schema. In this multi-center registry study conducted in China, we determine to explore the difference of prognosis and stroke recurrence of young patients with different ischemic stroke subtypes.

Enrollment

3,000 estimated patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 through 45 years, both genders
  • First-ever acute ischemic stroke
  • Onset of symptoms within 72 hours of inclusion
  • Willing to participate in follow-up visits

Exclusion criteria

  • Silent stroke
  • Failure to give their informed consent

Trial design

3,000 participants in 1 patient group

Young adult stroke patients
Description:
Young adult (18-45 years old) patients with confirmed first-ever acute ischemic stroke
Treatment:
Other: Treatment following current guidelines

Trial contacts and locations

1

Loading...

Central trial contact

Zhenni Guo, MD; Yi Yang, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems